Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
about
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP componentAdenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adultsProtection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice.New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response.Plasmodium-host interactions directly influence the threshold of memory CD8 T cells required for protective immunityDNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses.Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.Prospects for developing an effective vaccine against ocular herpes simplex virus infection.Protective and pathogenic roles of CD8+ T cells during malaria infection.Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yClinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAMemory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria.Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malariaCellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro.Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine.
P2860
Q28744136-81880860-170F-43B4-99E7-CAA15C0D3D63Q28744149-72A64CF2-2BA9-40D9-867D-E374B2274A78Q33303670-EE6EABE2-79B2-4CB9-B4CB-6E180B45AA47Q33587443-E5B044EB-CA09-4D15-A8AB-090B771C430BQ33792633-6AEB6156-B24C-4E5E-90D3-586FD635C82DQ33818084-466518E7-9B71-4F12-92F1-C489D6E95C8AQ33868760-75056A8F-CAD3-4359-AC81-F5F2C083743BQ33997771-79836068-6A4A-4577-9A74-43B427E72B5DQ34274515-14477FF2-AEA5-4C45-A570-CBD85DC54C94Q34782568-2514606E-8324-470E-BF31-B1F38796CDB5Q34928329-79E0E8BC-2EE9-461A-90A2-09C055A84D8CQ35165007-0D9D8AE5-3958-4471-A0C0-7AD3693A7359Q35771456-A89ADC17-DF11-4265-A490-5117E1B52267Q36311038-5840EB84-29B2-42C7-B09D-5172BBD8BDFFQ36378328-43A89740-FD79-4FFF-915E-099224D2CAF9Q36541222-0B3278FF-0A53-4A14-A3ED-4C1B37BFA9B0Q36694820-CE1D3776-7AA6-4E41-B0DC-B1874A697621Q36893651-1AB32A15-B454-4D84-BE52-9F86A71B6E5DQ37146236-1D07E112-9659-4920-BA71-E02699CC8B8DQ40213640-95FDEAFB-32C1-43A2-9D2F-1ABE9C8BF0E2Q53702329-8265AA04-290F-4A4D-BDB7-F584ADCF47DC
P2860
Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Persistence of protective immu ...... ion of effector and memory CD8
@nl
Persistence of protective immu ...... ory CD8(+)-T-cell populations.
@ast
Persistence of protective immu ...... ory CD8(+)-T-cell populations.
@en
type
label
Persistence of protective immu ...... ion of effector and memory CD8
@nl
Persistence of protective immu ...... ory CD8(+)-T-cell populations.
@ast
Persistence of protective immu ...... ory CD8(+)-T-cell populations.
@en
prefLabel
Persistence of protective immu ...... ion of effector and memory CD8
@nl
Persistence of protective immu ...... ory CD8(+)-T-cell populations.
@ast
Persistence of protective immu ...... ory CD8(+)-T-cell populations.
@en
P2093
P2860
P1476
Persistence of protective immu ...... ory CD8(+)-T-cell populations.
@en
P2093
Arnel Belmonte
Daniel J Carucci
Denise L Doolan
Gary T Brice
Maria Belmonte
Trevor R Jones
Victoria F Majam
William O Rogers
Yupin Charoenvit
P2860
P304
P356
10.1128/IAI.70.7.3493-3499.2002
P407
P577
2002-07-01T00:00:00Z